Patricia Allen, CFO at Larimar Therapeutics, holds 0.00 shares in Larimar Therapeutics (Ticker: LRMR), holds 0.00 shares in Deciphera Pharmaceuticals (Ticker: DCPH), holds ― shares in Kineta (Ticker: KANT). Most recently, Patricia Allen ― shares of Larimar Therapeutics on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Patricia Allen?
The percentage of profitable transactions made by Patricia Allen is 0%.
What is the average return per transaction made by Patricia Allen?
The average return per transaction made by Patricia Allen is -20.30%.
What stocks does Patricia Allen hold?
Patricia Allen holds: LRMR, DCPH, KANT, ZBIO, ALNY stocks.
What was Patricia Allen’s latest transaction?
Patricia Allen latest transaction was an Uninformative Buy of ―.
What was Patricia Allen's most profitable transaction?
Patricia Allen’s most profitable transaction was an Informative Buy of ZBIO stock on February 13, 2026. The return on the trade was -8.90%.
What is Patricia Allen's role in Larimar Therapeutics?
Patricia Allen's role in Larimar Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.